|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:academic_programs
|
Ms. P. R. Iyer
|
|
gptkbp:acquisition
|
Niche Generics
Inva Gen Pharmaceuticals
|
|
gptkbp:advertising
|
Mr. S. K. Jain
Mr. A. K. Gupta
Mr. P. K. Agarwal
|
|
gptkbp:awards
|
numerous industry awards
|
|
gptkbp:categories
|
vaccines
biologics
prescription medications
nutraceuticals
OTC products
|
|
gptkbp:ceo
|
Umang Vohra
|
|
gptkbp:clinical_trial
|
conducts regularly
|
|
gptkbp:focus
|
affordable healthcare
|
|
gptkbp:founded
|
gptkb:1935
|
|
gptkbp:founder
|
Yusuf Hamied
|
|
gptkbp:global_presence
|
yes
|
|
gptkbp:has_authority_over
|
Mr. V. K. Sharma
|
|
gptkbp:head
|
Mr. R. K. Mehta
|
|
gptkbp:head_of_state
|
gptkb:Dr._R._S._Sharma
Ms. N. S. Rao
|
|
gptkbp:headquarters
|
gptkb:Mumbai
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Cipla
|
|
gptkbp:industry
|
gptkb:pharmaceuticals
|
|
gptkbp:invention
|
holds numerous
|
|
gptkbp:market_share
|
significant in India
|
|
gptkbp:number_of_employees
|
over 25,000
|
|
gptkbp:operates_in
|
over 80 countries
|
|
gptkbp:partnership
|
gptkb:MSF
gptkb:Gilead_Sciences
gptkb:UNICEF
gptkb:WHO
|
|
gptkbp:products
|
generic drugs
|
|
gptkbp:research_and_development
|
significant investment
Dr. Ranjit Roy Chaudhury
|
|
gptkbp:research_areas
|
gptkb:diabetes
gptkb:HIV/_AIDS
cardiology
neurology
oncology
respiratory
|
|
gptkbp:revenue
|
$2.2 billion (2020)
|
|
gptkbp:social_responsibility
|
active in CSR
|
|
gptkbp:stock_exchange
|
gptkb:BSE
NSE
|
|
gptkbp:supply_chain
|
Mr. A. S. Verma
|
|
gptkbp:sustainability_initiatives
|
community health programs
environmental responsibility
employee welfare programs
|
|
gptkbp:bfsParent
|
gptkb:P._V._Sindhu
|
|
gptkbp:bfsLayer
|
5
|